Lipitor Litigation’s Last Gasp?

Is This Lipitor Litigation’s Last Gasp? may have got a lucky break in the Lipitor multidistrict litigation (MDL).

The popular statin drug used to treat high cholesterol has been linked to the development of type-2 diabetes.

Based on a recent judicial order, the Lipitor MDL plaintiffs …

Original post

Beyond Lipitor Type 2 Diabetes, a New Concern with Statins

Bangor, ME
Among the ongoing concerns over the statin Lipitor are the potential for type 2 diabetes and cognitive issues such as memory and concentration.

Atorvastatin (Lipitor) type 2 diabetes remains one of the biggest frustrations alleged in …

Original post

Former Pfizer employee loses another bid to press illegal marketing lawsuit

A federal appeals court last week refused 1 to revive a lawsuit in which a former Pfizer employee alleged the company promoted off-label use of its Lipitor cholesterol pill.

In doing so, however, the court also raised a question about the extent to …

Original post

Over 2400 Lipitor Diabetes Lawsuits Filed in Federal Court, More Expected against Pfizer alleging that its blockbuster cholesterol drug Lipitor (atorvastatin) – a statin taken by millions of Americans – caused Type 2 diabetes continue to mount, as the first bellwether cases in federal multidistrict litigation (MDL …

Read the original story here

Pfizer Wins Lipitor Lawsuit in Australia

Melbourne, Australia Pfizer may have lost its motion to dismiss in Lipitor lawsuits in the US, but the drugmaker is celebrating a victory in Australia.

An Australian consumer watchdog filed a Lipitor lawsuit against Pfizer, alleging the company engaged …

Read the original story here

Pfizer’s Attempt to Toss Lawsuits in Lipitor Diabetes Lawsuits MDL Rejected

Charleston, SC The manufacturer of Lipitor recently attempted to cast off 10 atorvastatin type 2 diabetes cases in the Lipitor Diabetes Lawsuits MDL on grounds that failure-to-warn claims made by the plaintiffs were preempted by federal regulation …

Read the original story here

Pfizer Can’t Duck 10 Lipitor Diabetes Claims

A South Carolina federal judge on Monday nixed Pfizer Inc.’s attempt to duck 10 cases in multidistrict litigation over claims that its cholesterol drug Lipitor can cause diabetes, saying that their …

Read the full article

Lipitor Lawsuits Climbing but Pfizer Digging In

New York, NY As the number of cases in the Lipitor Diabetes Lawsuits MDL continue to spike, Lipitor manufacturer Pfizer Inc. continues to position itself following the expiration of its patent in November 2011. One of those moves, as evidenced by a …

Original post

Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor Inc and India’s Ranbaxy Laboratories Ltd on Friday won dismissal of a U.S. antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor. U.S. District Judge Peter Sheridan in …

Read the original article

Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *